BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today
BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股市新闻、股票咨询和交易提示
Shares of BIOLASE (NASDAQ:BIOL), a company that specializes in dental lasers, was up 20% in pre-market trading after it was granted a reprieve by the Nasdaq stock exchange.
的股份生物酶纳斯达克：BIOL是一家专门从事牙科激光的公司，在获得政府批准暂缓上市后，该公司在盘前交易中上涨了20%.纳斯达克证券交易所。
At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news release, BIOLASE announced that it has been granted a 180-day extension to regain compliance with this requirement.
以每股47美分的价格出售的Biol股票面临被纳斯达克摘牌的危险，后者要求公司维持1美元的最低股价才能留在交易所。然而，在一份新闻稿中，BIOLASE宣布它已获准延期180天，以重新遵守这一要求。
What Happened With BIOL Stock
Biol Stock发生了什么？
Nasdaq has told BIOLASE that it has until May 23, 2022 to get its share price above $1 and keep it there for a minimum of 10 consecutive trading days. If it can do that, it will regain compliance with the exchange and avoid being delisted. That extension buys BIOLASE some much-needed time to raise its stock from its current price.
纳斯达克已经告诉Biolase，它必须在2022年5月23日之前让股价升至更高水平$1并在那里保持至少连续10个交易日。如果它能做到这一点，它将重新遵守交易所的规定，并避免被摘牌。这一延期为BIOLASE赢得了一些亟需的时间，以提高其股票在当前价格的基础上。
Investors have welcomed the news, judging by the fact that BIOL stock shot up more than 20% before the opening bell. Although shares have cooled off slightly, they are still up 12% in morning trading.
投资者对这一消息表示欢迎，因为Biol的股价在开盘前飙升了20%以上。尽管股价略有降温，但在早盘交易中仍上涨了12%。
BIOL stock has been on a steady decline for several years now. A publicly traded company since 1992, its stock had been trading at just under $100 per share in 2004. However, since that peak, the share price has steadily eroded. In 2013, the shares were trading at $25 and they have slid lower and lower since.
Biol的库存几年来一直在稳步下降。该公司自1992年以来一直是一家上市公司，2004年的股价略低于每股100美元。然而，自那次峰值以来，股价一直在稳步下跌。2013年，该公司股价为25美元，此后不断下滑。
Why It Matters
为什么这很重要
The extension by Nasdaq removes some immediate uncertainty surrounding BIOL stock. It also gives the Foothill Ranch, California-based company time to improve its financials, gain the confidence of investors, and push its stock price above the $1 minimum needed to remain on the Nasdaq. It is a positive development for BIOLASE in the near term.
纳斯达克的延期消除了围绕生物股票的一些迫在眉睫的不确定性。这也给了这家总部位于加利福尼亚州山麓牧场的公司时间来改善其财务状况，赢得投资者的信心，并将其股价推高至1美元以上，这是留在纳斯达克所需的最低价格。这在短期内对BIOLASE来说是一个积极的发展。
However, the 180-day extension by Nasdaq does not remove the longer-term issues facing the dental company or change the fact that its shares have collapsed over the last 15 years. Should BIOLASE fail to get its share price above $1 between now and May, it will be removed from the Nasdaq and likely end up trading on the over-the-counter market, also known as the pink sheets.
然而，纳斯达克的180天延期并没有消除这家牙科公司面临的长期问题，也没有改变其股价在过去15年里暴跌的事实。如果从现在到5月，Biolase的股价未能超过1美元，它将被从纳斯达克中除名，很可能最终在场外交易市场(也被称为粉单)进行交易。
Trading on the over-the-counter market could impact BIOL stock's liquidity, access to capital, and the ability of investors to access the company's shares.
在场外交易市场上的交易可能会影响Biol股票的流动性、获得资本的渠道以及投资者获得该公司股票的能力。
What's Next for BIOLASE
BIOLASE的下一步是什么
Today's gains are a step in the right direction for BIOL stock. But this doesn't solve the need for BIOLASE to get its share price up above $1 and keep it there for 10 consecutive days.
今天的涨幅是Biol股票朝着正确方向迈出的一步。但这并不能解决BIOLASE股价升至1美元上方并连续10天保持在这一水平的需要。
The Nasdaq extension buys the company some sorely needed time, but BIOLASE will need to use that time to come up with a plan to right its ship and get its shares moving in the right direction.
纳斯达克的延期为该公司赢得了一些亟需的时间，但Biolase需要利用这些时间拿出一个计划，让它重整旗鼓，让它的股票朝着正确的方向前进。
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That's because these "penny stocks" are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com's writers disclose this fact and warn readers of the risks.
关于细价股和低成交量股票： 除了极少数例外，不会发布关于市值低于1亿美元或每天交易量低于100,000股的公司的评论。这是因为这些“廉价股”经常是诈骗艺术家和市场操纵者的游乐场。如果我们确实发布了可能受我们的评论影响的低成交量股票的评论，我们要求 InvestorPlace.com该书的作者披露了这一事实，并警告读者其中的风险。
Read More: Penny Stocks — How to Profit Without Getting Scammed
更多阅读： 便士股票-如何在不上当的情况下获利
On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版之日，乔尔·巴格洛(Joel Baglole)没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点，以InvestorPlace.com发布指南为准.
The post BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today appeared first on InvestorPlace.
Bio Stock Alert的帖子：鲜为人知的BIOLASE今天为何飙升--首先出现在InvestorPlace上。